Improved in vitro evaluation of novel antimicrobials: potential synergy between human plasma and antibacterial peptidomimetics, AMPs and antibiotics against human pathogenic bacteria

Linda Citterio, Henrik Franzyk, Yaseelan Palarasah, Thomas Emil Andersen, Ramona Valentina Mateiu, Lone Gram

    Research output: Contribution to journalJournal articleResearchpeer-review

    Abstract

    Stable peptidomimetics mimicking natural antimicrobial peptides (AMPs) have emerged as a promising class of potential novel antibiotics. In the present study, we aimed at determining whether the antibacterial activity of two α-peptide/β-peptoid peptidomimetics against a range of bacterial pathogens was affected by conditions mimicking in vivo settings. Their activity was enhanced to an unexpected degree in the presence of human blood plasma for thirteen pathogenic Gram-positive and Gram-negative bacteria. MIC values typically decreased 2- to 16-fold in the presence of a human plasma concentration that alone did not damage the cell membrane. Hence, MIC and MBC data collected in these settings appear to represent a more appropriate basis for in vivo experiments preceding clinical trials. In fact, concentrations of peptidomimetics and peptide antibiotics (e.g. polymyxin B) required for in vivo treatments might be lower than traditionally deduced from MICs determined in laboratory media. Thus, antibiotics previously considered too toxic could be developed into usable last-resort drugs, due to ensuing lowered risk of side effects. In contrast, the activity of the compounds was significantly decreased in heat-inactivated plasma. We hypothesize that synergistic interactions with complement proteins and/or clotting factors most likely are involved.
    Original languageEnglish
    JournalResearch in Microbiology
    Volume167
    Issue number2
    Pages (from-to)72-82
    Number of pages11
    ISSN0923-2508
    DOIs
    Publication statusPublished - 2016

    Keywords

    • Antimicrobial peptide
    • Peptidomimetics
    • Antibiotics
    • Plasma
    • Synergy

    Fingerprint

    Dive into the research topics of 'Improved in vitro evaluation of novel antimicrobials: potential synergy between human plasma and antibacterial peptidomimetics, AMPs and antibiotics against human pathogenic bacteria'. Together they form a unique fingerprint.

    Cite this